Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, 221 Longwood Avenue, RFB 386, Boston, Massachusetts 02115, USA.
Eur J Endocrinol. 2011 Jun;164(6):995-1002. doi: 10.1530/EJE-11-0025. Epub 2011 Mar 14.
Previous studies have suggested that circulating adiponectin concentrations are associated positively with vitamin D and negatively with body mass index (BMI) but have not accounted for the influence of the renin-angiotensin-aldosterone system (RAAS) in this relationship. This is particularly relevant because increased RAAS activity is associated with obesity and is known to lower adiponectin levels. We evaluated the association between adiponectin and 25-hydroxyvitamin D (25(OH)D) after controlling RAAS activity with dietary sodium equilibration and also evaluated whether this relationship was influenced by BMI.
Cross-sectional study of 115 hypertensive Caucasian men from the Hypertensive Pathotype Consortium.
To manipulate RAAS activity, all subjects underwent 1 week of high dietary sodium (HS) diet to suppress RAAS and 1 week of low dietary sodium (LS) diet to stimulate RAAS. Linear regression was used to evaluate the association between adiponectin and 25(OH)D, and the effect of BMI on this relationship, in each dietary condition.
Adiponectin was higher on HS, where circulating RAAS activity was low, when compared with LS (HS=2.9 versus LS=2.4 μg/ml, P<0.0001). 25(OH)D levels were positively associated with adiponectin, and BMI was a statistically significant effect modifier of the relationship between 25(OH)D and adiponectin on both diets (P interaction <0.01 between BMI and 25(OH)D).
Higher 25(OH)D concentrations were independently associated with higher adiponectin levels, particularly when BMI was high. Dietary sodium balance and circulating RAAS activity did not appear to affect this relationship. Future studies should explore whether vitamin D supplementation increases adiponectin levels in obesity.
之前的研究表明,循环脂联素浓度与维生素 D 呈正相关,与体重指数(BMI)呈负相关,但并未考虑到肾素-血管紧张素-醛固酮系统(RAAS)在这种关系中的影响。这一点尤其重要,因为 RAAS 活性增加与肥胖有关,已知会降低脂联素水平。我们评估了在通过饮食钠平衡控制 RAAS 活性后,脂联素与 25-羟维生素 D(25(OH)D)之间的关系,并且还评估了这种关系是否受 BMI 影响。
高血压表型联盟中 115 名白种高血压男性的横断面研究。
为了操纵 RAAS 活性,所有受试者接受 1 周高钠饮食(HS)以抑制 RAAS 和 1 周低钠饮食(LS)以刺激 RAAS。线性回归用于评估在每种饮食条件下脂联素与 25(OH)D 之间的关系,以及 BMI 对这种关系的影响。
HS 时脂联素更高,此时循环 RAAS 活性较低,而 LS 时脂联素较低(HS=2.9 与 LS=2.4μg/ml,P<0.0001)。25(OH)D 水平与脂联素呈正相关,并且 BMI 是 25(OH)D 和脂联素之间关系的统计学显著的效应修饰因子,在两种饮食中(P 交互<0.01)。
较高的 25(OH)D 浓度与较高的脂联素水平独立相关,尤其是在 BMI 较高时。饮食钠平衡和循环 RAAS 活性似乎没有影响这种关系。未来的研究应该探索维生素 D 补充是否会增加肥胖症患者的脂联素水平。